← Leaderboards
Thomas Harbin
Eye Consultants Of Atlanta, P.C.
$664,408
Attributed
$664,408
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $92.9K · FY2005–08$100K$75K$50K$25K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$664,408 · 1
By mechanism
U10$664,408 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsEye Disorder DiagnosisDisease /Disorder Prevention /ControlHuman SubjectHuman Therapy EvaluationGlaucomaEye Disorder ChemotherapyCooperative StudyMedical SpecialitiesNumbersOcular HypertensionPerformanceProceduresRandomizedAbstractingResearch PersonnelAreaCaringDesignDocumentationEnrollmentHypertension TreatmentManuals
Grant awards (7)
OCULAR HYPERTENSION TREATMENT STUDY (OHTS) SPECIALTY EYE CARE$92,941
U10 · FY2008 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS) SPECIALTY EYE CARE$90,237
U10 · FY2007 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS) SPEC EYE CARE$87,608
U10 · FY2006 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS) SPEC EYE CARE$85,056
U10 · FY2005 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS) SPEC EYE CARE$82,577
U10 · FY2004 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS) SPEC EYE CARE$97,724
U10 · FY2003 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS) SPEC EYE CARE$128,265
U10 · FY2002 · EY